State Street’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

State Street’s Portfolio FOMX Stock Details FOMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-48,776	Closed	-$162K	–	3819
2019 Q4	$162K	Sell	48,776 -732	-1%	-$2.33K	﹤0.01%	3654
2019 Q3	$151K	Hold	49,508	–	–	﹤0.01%	3634
2019 Q2	$118K	Hold	49,508	–	–	﹤0.01%	3653
2019 Q1	$186K	Sell	49,508 -1,491	-3%	-$5.59K	﹤0.01%	3583
2018 Q4	$183K	Buy	50,999 +4,299	+9%	+$18.7K	﹤0.01%	3589
2018 Q3	$268K	Buy	+46,700	New	+$267K	﹤0.01%	3555
2016 Q2	–	Sell	-293,003	Closed	-$1.91M	–	3799
2016 Q1	$1.91M	Buy	293,003 +11,776	+4%	+$75.9K	﹤0.01%	3023
2015 Q4	$2.28M	Buy	281,227 +40,700	+17%	+$304K	﹤0.01%	2947
2015 Q3	$1.76M	Buy	240,527 +61,388	+34%	+$626K	﹤0.01%	3045
2015 Q2	$1.84M	Buy	+179,139	New	+$1.98M	﹤0.01%	3085

State Street's FOMX Position: Q1 2020 in Review

State Street sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2020, closing a stake of 48,776 shares — an estimated $162K sold.

State Street first reported a position in FOMX in Q2 2015 and held it in 10 quarters. The position peaked at $2.28M in Q4 2015. 3 funds tracked by Wall St. Rank hold FOMX as of Q1 2020.

State Street reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
State Street sold 48,776 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2020, an estimated $162K.
State Street first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q2 2015 and held it in 10 quarters.
State Street's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $2.28M in Q4 2015.
3 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2020.

Based on State Street's 13F filing for Q1 2020, filed 11 May 2020.